Cytora Stem

Cytora Stem is a pioneering pharmaceutical manufacturing company dedicated to developing a new class of medicines derived from human Oral Mucosa Stem Cells (hOMSC). With a revolutionary, patent-protected technology platform, Cytora Stem is producing "off the shelf" (allogeneic) therapeutic doses of hOMSC to address some of the most challenging diseases, including chronic wounds like incurable diabetic foot ulcers (IDFU) and degenerative diseases such as Parkinson's Disease, Multiple System Atrophy (MSA), and Alzheimer’s Disease.

Cytora Stem's vision is to improve and save the lives of millions of patients worldwide through its unique patented stem cell platform technology, making it accessible and affordable. The company's deeply scientific team leads the way in stem cell therapy, bringing years of research, patents, and industry experience in biotechnology and stem cell therapy to the forefront of medical innovation.

Based in Yokneam, Cytora Stem is committed to advancing healthcare through groundbreaking stem cell solutions. We invite the management of Cytora Stem to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.